BeOne Medicines (ONC) Interest & Investment Income (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Interest & Investment Income of $27.7 million for Q1 2026, up 115.28% year-over-year from $12.8 million in Q1 2025, and up 115.28% quarter-over-quarter from $12.8 million in Q1 2025.
BeOne Medicines (ONC) Interest & Investment Income (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Interest & Investment Income for 4 consecutive years, with $27.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 115.28% year-over-year to $27.7 million; the TTM figure through Mar 2026 stood at $41.0 million (up 196.67% YoY), while the FY2025 annual figure was $70.5 million, up 1.24% from the prior year.
- Interest & Investment Income rose to $27.7 million in Q1 2026 per ONC's latest filing, from $12.8 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $27.7 million in Q1 2026 and bottomed at $12.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 36.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.90 Mn |
| Mar 31, 2026 | 27.66 Mn |
| Mar 31, 2025 | 12.85 Mn |
| Sep 30, 2016 | 209,000.00 |
| Jun 30, 2016 | 262,000.00 |
| Mar 31, 2016 | 494,000.00 |
| Sep 30, 2015 | 760,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Mar 31, 2015 | 117,000.00 |